search
Back to results

Preventing Malaria During Pregnancy in Epidemic-prone Areas.

Primary Purpose

Malaria, Falciparum

Status
Completed
Phase
Phase 3
Locations
Uganda
Study Type
Interventional
Intervention
Intermittent preventive treatment:sulphadoxine-pyrimethamine
Insecticide-treated mosquito bed net
Sponsored by
London School of Hygiene and Tropical Medicine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Malaria, Falciparum focused on measuring malaria, pregnancy, intermittent preventive treatment, insecticide-treated nets

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria: Pregnant women whose pregnancies are at <27 weeks gestation at first antenatal booking Permanent resident in study area Informed consent Exclusion Criteria: Late presentation: pregnancies more than 26 weeks gestation at first antenatal booking Severe anaemia (Hb<70g/L) on enrolment Previous reaction to a sulfa-drug (e.g. sulphadoxine-pyrimethamine, septrin) History of severe skin reaction to any drug Current (or history) of severe disease (e.g. hepatitis, jaundice, TB, AIDS) Withdrawal Criteria: Withdrawal of consent Women developing severe anaemia (Hb<70g/L)during pregnancy

Sites / Locations

  • Kabale District Health Services (antenatal clinics at selected sites)

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Active Comparator

Arm Label

1

2

3

Arm Description

Drug: Intermittent preventive treatment:sulphadoxine-pyrimethamine

Device: Insecticide-treated mosquito bed net

Combination of Drug + Device: Drug: Intermittent preventive treatment:sulphadoxine-pyrimethamine Device: Insecticide-treated mosquito bed net

Outcomes

Primary Outcome Measures

mean birthweight
prevalence of low birthweight

Secondary Outcome Measures

maternal anaemia - mean Hb at gestational age 36 weeks, prevalence of Hb<100g/L at gestational age 36 weeks
spontaneous abortions
stillbirths

Full Information

First Posted
August 31, 2005
Last Updated
January 11, 2017
Sponsor
London School of Hygiene and Tropical Medicine
Collaborators
Ministry of Health, Uganda
search

1. Study Identification

Unique Protocol Identification Number
NCT00142207
Brief Title
Preventing Malaria During Pregnancy in Epidemic-prone Areas.
Official Title
The Efficacy and Cost-effectiveness of Malaria Prevention in Pregnancy in an Area of Low and Unstable Transmission in Kabale, Uganda: Use of Intermittent Preventive Treatment and Insecticide-treated Nets.
Study Type
Interventional

2. Study Status

Record Verification Date
January 2017
Overall Recruitment Status
Completed
Study Start Date
January 2004 (undefined)
Primary Completion Date
January 2007 (Actual)
Study Completion Date
January 2007 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
London School of Hygiene and Tropical Medicine
Collaborators
Ministry of Health, Uganda

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to compare the efficacy and cost-effectiveness of three alternative strategies for the prevention of malaria during pregnancy in an epidemic-prone area of low transmission in the East African Highlands. The strategies being compared are: intermittent preventive treatment with sulfadoxine-pyrimethamine (IPT-SP) an insecticide treated net (ITN), and intermittent preventive treatment with SP plus an ITN In addition to the main individually-randomised trial, outcome data was subsequently also gathered on pregnant women whose houses where sprayed with indoor residual insecticides (IRS) as part of a non-randomised district-wide control programme to compare the impact of IRS with the three intervention arms.
Detailed Description
Susceptibility to malaria infection during pregnancy and the severity of clinical manifestation are determined by the level of pre-pregnancy immunity, which depends on intensity and stability of malaria transmission. Most intervention trials to prevent malaria during pregnancy have been conducted in areas of intense transmission. The results of trials conducted in high-transmission areas may not be applicable to low transmission areas, where malaria is less frequent but the risk of spontaneous abortion and stillbirth is very high in women of all parities due to lack of sufficient malaria immunity. Routine chemoprophylaxis is generally not recommended in areas of unstable malaria transmission. However, intermittent treatment with an effective anti-malarial drug may be beneficial, especially during periods of malaria transmission. Little work has been carried out amongst pregnant women living in areas of low and unstable transmission in Africa. No data are available on the cost-effectiveness of malaria control in low transmission settings. This study will compare the efficacy and cost effectiveness of three preventive strategies for the control of malaria during pregnancy in low-transmission settings. The study is located in Kabale district, a highland area in SW Uganda. Women attending antenatal care are randomised to receive either: intermittent preventive treatment with sulfadoxine-pyrimethamine (IPT-SP) an insecticide treated net (ITN), or intermittent preventive treatment with SP and an ITN. It is hypothesized that when combined with IPT-SP, the additional impact of ITNs by reducing exposure may be greatest where the intensity of transmission is low. In addition to the main individually-randomised trial, outcome data was subsequently also gathered on pregnant women whose houses where sprayed with indoor residual insecticides (IRS) as part of a non-randomised district-wide control programme to compare the impact of IRS with the three intervention arms. The study aims to identify the most effective intervention strategies suited to areas characterised by low and unstable transmission. Research findings should be applicable to other hypoendemic areas of the East African highlands.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Malaria, Falciparum
Keywords
malaria, pregnancy, intermittent preventive treatment, insecticide-treated nets

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
4775 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Active Comparator
Arm Description
Drug: Intermittent preventive treatment:sulphadoxine-pyrimethamine
Arm Title
2
Arm Type
Active Comparator
Arm Description
Device: Insecticide-treated mosquito bed net
Arm Title
3
Arm Type
Active Comparator
Arm Description
Combination of Drug + Device: Drug: Intermittent preventive treatment:sulphadoxine-pyrimethamine Device: Insecticide-treated mosquito bed net
Intervention Type
Drug
Intervention Name(s)
Intermittent preventive treatment:sulphadoxine-pyrimethamine
Intervention Description
Two doses given twice during pregnancy (once in the second trimester, and once in the third trimester). Oral medication in tablet form: single daily dose given on each occasion
Intervention Type
Device
Intervention Name(s)
Insecticide-treated mosquito bed net
Intervention Description
Insecticide-treated mosquito bed net
Primary Outcome Measure Information:
Title
mean birthweight
Time Frame
April 2004-Jan 2007
Title
prevalence of low birthweight
Time Frame
April 2004 - Jan 2007
Secondary Outcome Measure Information:
Title
maternal anaemia - mean Hb at gestational age 36 weeks, prevalence of Hb<100g/L at gestational age 36 weeks
Time Frame
Feb 2003 - Jan 2007
Title
spontaneous abortions
Time Frame
Feb 2003 - Jan 2007
Title
stillbirths
Time Frame
April 2003-Jan 2007

10. Eligibility

Sex
Female
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Pregnant women whose pregnancies are at <27 weeks gestation at first antenatal booking Permanent resident in study area Informed consent Exclusion Criteria: Late presentation: pregnancies more than 26 weeks gestation at first antenatal booking Severe anaemia (Hb<70g/L) on enrolment Previous reaction to a sulfa-drug (e.g. sulphadoxine-pyrimethamine, septrin) History of severe skin reaction to any drug Current (or history) of severe disease (e.g. hepatitis, jaundice, TB, AIDS) Withdrawal Criteria: Withdrawal of consent Women developing severe anaemia (Hb<70g/L)during pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Richard H Ndyomugyenyi, MBChB, PhD
Organizational Affiliation
Vector Control Division, Ministry of Health, Uganda
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Sian E Clarke, PhD
Organizational Affiliation
London School of Hygiene and Tropical Medicine, University of London, UK
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Pascal Magnussen, MD
Organizational Affiliation
DBL - Institute for Health Research and Development, Denmark
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Kristian Schultz Hansen, PhD
Organizational Affiliation
DBL - Institute for Health Research and Development, Denmark
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kabale District Health Services (antenatal clinics at selected sites)
City
Kabale
State/Province
Kabale District
Country
Uganda

12. IPD Sharing Statement

Citations:
Citation
Ndyomugyenyi R, Clarke S, Chandramohan D, Twesigomwe T & Magnussen P. (2005). Epidemiology of pregnancy-associated malaria in the Ugandan highlands [abstract]. Acta Tropica, Suppl 95: S448.
Results Reference
background
PubMed Identifier
24030879
Citation
Hansen KS, Ndyomugyenyi R, Magnussen P, Clarke SE. Cost-effectiveness analysis of three health interventions to prevent malaria in pregnancy in an area of low transmission in Uganda. Int Health. 2012 Mar;4(1):38-46. doi: 10.1016/j.inhe.2011.10.001.
Results Reference
derived
PubMed Identifier
21962292
Citation
Ndyomugyenyi R, Clarke SE, Hutchison CL, Hansen KS, Magnussen P. Efficacy of malaria prevention during pregnancy in an area of low and unstable transmission: an individually-randomised placebo-controlled trial using intermittent preventive treatment and insecticide-treated nets in the Kabale Highlands, southwestern Uganda. Trans R Soc Trop Med Hyg. 2011 Nov;105(11):607-16. doi: 10.1016/j.trstmh.2011.07.012. Epub 2011 Oct 2.
Results Reference
derived

Learn more about this trial

Preventing Malaria During Pregnancy in Epidemic-prone Areas.

We'll reach out to this number within 24 hrs